Differences in Adverse Drug Events Among Pediatric Patients With and Without Cancer: Sub-Analysis of a Retrospective Cohort Study

Differences in Adverse Drug Events Among Pediatric Patients With and Without Cancer: Sub-Analysis... Drugs - Real World Outcomes (2017) 4:167–173 DOI 10.1007/s40801-017-0115-8 ORIGINAL RESEARCH ARTICLE Differences in Adverse Drug Events Among Pediatric Patients With and Without Cancer: Sub-Analysis of a Retrospective Cohort Study 1 2 1 1 • • • • Akira Koizumi Yoshinori Ohta Mio Sakuma Rika Okamoto 1 3,4 1 • • Chisa Matsumoto David W. Bates Takeshi Morimoto Published online: 4 August 2017 The Author(s) 2017. This article is an open access publication Abstract patients and 289 ADEs among 213 non-cancer patients (7.1 Objectives This study investigated the differences in the per patient vs. 0.25 per patient, respectively; p\ 0.0001). incidence and severity of adverse drug events (ADEs) in The most common medications associated with ADEs in pediatric patients with and without cancer. cancer patients were antitumor agents; in contrast, medi- Methods We used data from the Japan Adverse Drug cations associated with fatal or life-threatening ADEs in Events Study for pediatrics, a cohort study enrolling cancer patients were most often sedatives (25%) and blood pediatric inpatients at two tertiary care teaching hospitals in products (25%). Medications associated with fatal or life- Japan. ADEs were identified by on-site review of all threatening ADEs among non-cancer patients were most medical http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Drugs - Real World Outcomes Springer Journals

Differences in Adverse Drug Events Among Pediatric Patients With and Without Cancer: Sub-Analysis of a Retrospective Cohort Study

Loading next page...
 
/lp/springer_journal/differences-in-adverse-drug-events-among-pediatric-patients-with-and-nHmyEZ3ukh
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Pharmacotherapy; Pharmacology/Toxicology; Internal Medicine
ISSN
2199-1154
eISSN
2198-9788
D.O.I.
10.1007/s40801-017-0115-8
Publisher site
See Article on Publisher Site

Abstract

Drugs - Real World Outcomes (2017) 4:167–173 DOI 10.1007/s40801-017-0115-8 ORIGINAL RESEARCH ARTICLE Differences in Adverse Drug Events Among Pediatric Patients With and Without Cancer: Sub-Analysis of a Retrospective Cohort Study 1 2 1 1 • • • • Akira Koizumi Yoshinori Ohta Mio Sakuma Rika Okamoto 1 3,4 1 • • Chisa Matsumoto David W. Bates Takeshi Morimoto Published online: 4 August 2017 The Author(s) 2017. This article is an open access publication Abstract patients and 289 ADEs among 213 non-cancer patients (7.1 Objectives This study investigated the differences in the per patient vs. 0.25 per patient, respectively; p\ 0.0001). incidence and severity of adverse drug events (ADEs) in The most common medications associated with ADEs in pediatric patients with and without cancer. cancer patients were antitumor agents; in contrast, medi- Methods We used data from the Japan Adverse Drug cations associated with fatal or life-threatening ADEs in Events Study for pediatrics, a cohort study enrolling cancer patients were most often sedatives (25%) and blood pediatric inpatients at two tertiary care teaching hospitals in products (25%). Medications associated with fatal or life- Japan. ADEs were identified by on-site review of all threatening ADEs among non-cancer patients were most medical

Journal

Drugs - Real World OutcomesSpringer Journals

Published: Aug 4, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off